Riskpilot← Back to searchSign inGet full accessMetaCurUm Biotech AB
ABActiveOrg 5591636393Tvistevägen 48 CResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20180 employees
Revenue 2024
SEK 0
EBITDA margin
—
+97% vs 2023
Equity ratio
55.4%
Financial strength
Net profit 2024
SEK -56K
+98% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -104K | +97% |
| Net profit | SEK -56K | +98% |
| Total assets | SEK 3,6M | -12% |
| Equity | SEK 2M | -3% |
| Employees | 0 | — |
Legal name
MetaCurUm Biotech AB
Org number
5591636393
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
27 juni 2018
Share capital
SEK 110 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av en av Paulsson, Lars Urban de Chateau, Maarteni förening med en av Bäckström, Carl Torbjörn Landström, Marene Inga-Britt Dessutom har verkställande direktören rätt att teckna firmanbeträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall arbeta med att utveckla nya läkemedel och biomarkörer.
Address
Tvistevägen 48 C
Email
info@metacurum.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 278 | 116 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −176 | −3 065 | −5 850 | −3 334 | −104 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −176 | −3 065 | −5 850 | −3 334 | −104 |
| Net financials | — | — | 2 | 24 | 48 |
| Profit before tax | −176 | −3 065 | −5 849 | −3 310 | −56 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −176 | −3 065 | −5 849 | −3 310 | −56 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 074 | 2 346 | 5 298 | 4 067 | 3 596 |
| Equity | 694 | 915 | 3 058 | 2 049 | 1 993 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 381 | 1 431 | 2 240 | 2 018 | 1 602 |
| Total debt | 381 | 1 431 | 2 240 | 2 018 | 1 602 |
EBITDA margin
-10400000.0%
This company
15.8%
Market median
-65822885% vs market
20202024
Equity ratio
55.4%
This company
38.2%
Market median
+45% vs market
20202024
Return on equity
-2.8%
This company
18.4%
Market median
-115% vs market
20202024
Net profit margin
-5600000.0%
This company
8.1%
Market median
-69135902% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.80×
This company
0.62×
Market median
+29% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MD Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
LH Chief Executive Officer | Chief Executive Officer | 2020 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
| Chairman | 2022 | |
| Board of Directors | 2021 | |
| Board of Directors | 2020 | |
| Former (2) | ||
| Chairman | 2020 – 2021 | |
| Deputy Board Member | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MetaCurUm Biotech AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lotta Helena Berg | Chief Executive Officer | 0 companies |
| Maarten De Chateau | Chief Executive Officer | 0 companies |
| Stig Michael Sundström | Board of Directors | 0 companies |
| Lars Thomas Uhlin | Chairman | 0 companies |
| Carl-Gustaf Vilhelm Gölander | Deputy Board Member | 0 companies |
| Lars Urban Paulsson | Chairman | 0 companies |
| Ann Helen Fält | Deputy Board Member | 0 companies |
| Carl Torbjörn Bäckström | Board of Directors | 0 companies |
| Marene Inga-Britt Landström | Board of Directors | 0 companies |